Status:
COMPLETED
Effectiveness of Combined Albendazole and Ivermectin Treatment for Intestinal Worm Infections
Lead Sponsor:
Centers for Disease Control and Prevention
Collaborating Sponsors:
Universidad del Valle, Guatemala
Conditions:
Ascariasis
Trichuriasis
Eligibility:
All Genders
5-12 years
Phase:
NA
Brief Summary
The aim of this study is to compare the efficacy and impact on growth of two drug treatments against intestinal worms in schoolchildren from a rural area of Guatemala. According to the World Bank, the...
Detailed Description
The aim of this study is to compare the efficacy and nutritional impact of two drug treatments against intestinal helminths from a rural area of Guatemala. The helminths that will be analyzed in this ...
Eligibility Criteria
Inclusion
- Children will be eligible to participate in the study if they are between 5 and 12 years of age, are students in schools selected for study, and if parental consent and child assent for participation has been obtained.
Exclusion
- those not fitting criteria above
Key Trial Info
Start Date :
February 1 2005
Trial Type :
INTERVENTIONAL
End Date :
March 1 2005
Estimated Enrollment :
550 Patients enrolled
Trial Details
Trial ID
NCT00207753
Start Date
February 1 2005
End Date
March 1 2005
Last Update
November 17 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Various elementary schools
Poptún, Departamento del Petén, Guatemala